首页 | 本学科首页   官方微博 | 高级检索  
     

CDKN2B-AS1靶向miR-411-3p调节乳腺癌细胞的生物学行为
引用本文:孙宝峰,樊芳,李忠勇,李召霞. CDKN2B-AS1靶向miR-411-3p调节乳腺癌细胞的生物学行为[J]. 医学分子生物学杂志, 2020, 0(1): 26-32
作者姓名:孙宝峰  樊芳  李忠勇  李召霞
作者单位:兖矿新里程总医院甲乳外科
基金项目:山东省自然科学基金(No.ZR2017 MH078)。
摘    要:目的探究CDKN2B-AS1靶向miR-411-3p对乳腺癌MCF-7细胞的生物学行为的影响.方法将sh-CDKN2B-AS1、miR-411 inhibitor转染于MCF-7,再共同转染于MCF-7.检测各组细胞增殖、迁移、侵袭及蛋白表达.MCF-7及转染sh-CDKN2B-AS1的MCF-7接种于小鼠体内,为Ctrl及sh-CDK组,检测肿瘤组织CDKN2B-AS1、miR-411-3p、Ki67及VEGF.结果miR-411-3p是CDKN2B-AS1的靶向位点,相比于Ctrl组,sh-CDKN2B-AS1组CDKN2B-AS1、VEGF及P38表达量降低;miR-411-3p,ki67、HIF-1 a,Caspase-3表达量上升,细胞增殖数、侵袭数及迁移率降低(P均<0.05).与Ctrl组比较,sh-CDKN2B-AS1组肿瘤质量降低,肿瘤组织CDKN2B-AS1、ki67、VEGF表达量降低,miR-411-3p表达量上升(P均<0.05).结论抑制CDKN2B-AS1表达可靶向提升miR-411-3p水平,从而抑制乳腺癌细胞增殖、迁移、侵袭及移植瘤生长.

关 键 词:CDKN2B-AS1  miR-411-3p  乳腺癌  增殖  肿瘤

CDKN2B-AS1 Targets miR-411-3p to Regulate Biological Behavior of Breast Cancer Cells
SUN Baofeng,FAN Fang,LI Zhongyong,LI Zhaoxia. CDKN2B-AS1 Targets miR-411-3p to Regulate Biological Behavior of Breast Cancer Cells[J]. Journal of Medical Molecular Biology, 2020, 0(1): 26-32
Authors:SUN Baofeng  FAN Fang  LI Zhongyong  LI Zhaoxia
Affiliation:(Department of Breast Surgery Yan Kuang New Journey General Hospital,Zoucheng,Shandong,273500,China)
Abstract:Objective To investigate the effect of CDKN2B-AS1 targeting miR-411-3p on the biological behavior of breast cancer MCF-7 cells and transplanted tumors.Methods Sh-CDKN2B-AS1 and miR-411 inhibitor were transfected into MCF-7,and then co-transfected into MCF-7.Cell proliferation,migration,invasion and protein expression were detected in each group.MCF-7 and MCF-7 transfected with sh-CDKN2B-AS1 were inoculated in mice in the Ctrl and sh-CDK groups.CDKN2B-AS1,miR-411-3p,Ki67,and VEGF were detected in tumor tissues.Results miR-411-3p is the target site of CDKN2B-AS1.Compared with the Ctrl group,the expression levels of CDKN2B-AS1,VEGF and P38 in the sh-CDKN2B-AS1 group are reduced,Caspase-3 expres-sion increased,the number of cell proliferation,invasion and migration decreased(allP<0.05).Compared with the Ctrl group,the tumor mass of the sh-CDKN2B-AS1 group decreased,the expres-sion of CDKN2B-AS1,ki67,and VEGF decreased,and the expression of miR-411-3p increased(allP<0.05).Conclusion Inhibition of CDKN2B-AS1 expression can target miR-411-3p levels,thereby inhibiting breast cancer cell proliferation,migration,invasion and tumor growth.
Keywords:CDKN2B-AS1  miR-41l-3p  breast cancer  proliferation  tumors
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号